[Skip to Content]
[Skip to Content Landing]

Scalp Eruption in a Patient With Metastatic Colon Cancer

Educational Objective
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
1 Credit CME

A 73-year-old man with metastatic BRAF-mutant colorectal cancer presented with a 1-month history of crusted lesions with purulent drainage on the scalp, with associated pruritus and pain. Five months earlier he began treatment with cetuximab, binimetinib, and encorafenib, complicated by a grade 1 acneiform eruption that was managed with doxycycline hyclate and topical hydrocortisone and clindamycin phosphate. Oncologic therapy was withheld pending further evaluation of the scalp eruption. He had a distant history of actinic keratoses on the scalp treated with liquid nitrogen but otherwise denied previous skin cancer. Examination of the scalp revealed male pattern baldness, diffuse actinic damage, and multiple thick, yellow-brown crusts overlying erosions with purulent drainage (Figure 1). A wound culture was performed and grew methicillin-sensitive Staphylococcus aureus. A shave biopsy was obtained.

Please finish quiz first before checking answer.

You answered correctly!

Read the answer below and download your certificate.

You answered incorrectly.

Read the discussion below and retake the quiz.

A 73-year-old man with metastatic BRAF-mutant colorectal cancer presented with a 1-month history of crusted lesions with purulent drainage on the scalp, with associated pruritus and pain. Five months earlier he began treatment with cetuximab, binimetinib, and encorafenib, complicated by a grade 1 acneiform eruption that was managed with doxycycline hyclate and topical hydrocortisone and clindamycin phosphate. Oncologic therapy was withheld pending further evaluation of the scalp eruption. He had a distant history of actinic keratoses on the scalp treated with liquid nitrogen but otherwise denied previous skin cancer. Examination of the scalp revealed male pattern baldness, diffuse actinic damage, and multiple thick, yellow-brown crusts overlying erosions with purulent drainage (Figure 1). A wound culture was performed and grew methicillin-sensitive Staphylococcus aureus. A shave biopsy was obtained.

Survey Complete!

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Joseph Zikry, MD, Department of Dermatology, Keck School of Medicine, University of Southern California, 1441 Eastlake Ave, Ezralow Tower, Ste 5301, Los Angeles, CA 90033 (zikryj@gmail.com).

Published Online: November 12, 2020. doi:10.1001/jamaoncol.2020.5176

Conflict of Interest Disclosures: None reported.

Additional Contributions: We thank the patient for granting permission to publish this information.

References
1.
Wilk  M , Zelger  BG , Hauser  U , Höpfl  R , Zelger  B .  Erosive pustular dermatosis of the scalp: reappraisal of an underrecognized entity.   J Dtsch Dermatol Ges. 2018;16(1):15-19. doi:10.1111/ddg.13387 PubMedGoogle Scholar
2.
Tomasini  C , Michelerio  A .  Erosive pustular dermatosis of the scalp: a neutrophilic folliculitis within the spectrum of neutrophilic dermatoses: a clinicopathologic study of 30 cases.   J Am Acad Dermatol. 2019;81(2):527-533. doi:10.1016/j.jaad.2018.10.029 PubMedGoogle ScholarCrossref
3.
Lee  KH , Carley  SK , Kraus  CN , Mesinkovska  NA .  Treatment of erosive pustular dermatosis: a systematic review of the literature.   Int J Dermatol. 2020;59(7):770-786. doi:10.1111/ijd.14744 PubMedGoogle ScholarCrossref
4.
Guggina  L , Choi  A , Choi  J .  EGFR inhibitors and cutaneous complications: a practical approach to management.   Oncol Ther. 2017;5:135–148. doi:10.1007/s40487-017-0050-6Google ScholarCrossref
5.
Toda  N , Fujimoto  N , Kato  T ,  et al.  Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors.   Dermatology. 2012;225(1):18-21. doi:10.1159/000341528 PubMedGoogle ScholarCrossref
6.
Heinzerling  L , Eigentler  TK , Fluck  M ,  et al.  Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.   ESMO Open. 2019;4(3):e000491. doi:10.1136/esmoopen-2019-000491 PubMedGoogle Scholar
7.
Fukui  T , Kitamura  H , Harada  K , Nakano  H , Sawamura  D .  Trichoscopic findings of erosive pustular dermatosis of the scalp associated with gefitinib.   Case Rep Dermatol. 2017;9(2):44-49. doi:10.1159/000475543 PubMedGoogle ScholarCrossref
8.
Peters  P , Bissex  C , Gajra  J , Rubel  D .  Erosive pustular dermatosis of the scalp following cetuximab.   Hong Kong J Dermatol Venereol. 2014;22(3):131-134.Google Scholar
9.
Wu  CY , Chen  GS , Lan  CC .  Erosive pustular dermatosis of the scalp after gefitinib and radiotherapy for brain metastases secondary to lung cancer.   Clin Exp Dermatol. 2008;33(1):106-107.PubMedGoogle Scholar
10.
Goto  K , Nomura  T , Kogame  T ,  et al.  Improvement of erosive pustular dermatosis of the scalp following discontinuation of chemotherapy with afatinib.   Eur J Dermatol. 2018;28(2):258-259. doi:10.1684/ejd.2018.3220 PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close